21st Dubai Conference and Expo

ON

Psychiatry and Neuropsychology

Event Date

February 25-26, 2025

Venue

Dubai, UAE

– QUICK LINKS –

– Previous Conference Performers / Professionals From Around The Globe

Ahmed Ali

Ahmed Ali

  • Diyala University, Iraq
Aikaterini Ziaka

Aikaterini Ziaka

  • Physio4you, Greece
amr

AMR Hawal

  • Professor, Prime Healthcare Group UAE
Antonio Steardo

Antonio Steardo

  • University of Salerno, Italy
Ashraf Lotfy Fayed

Ashraf Lotfy Fayed

  • ENT Military Hospital, Egypt
aspazija

Aspazija Sofijanova

  • Director of Pediatric Clinic, Macedonia
Brandon P. Lucke-Wold

Brandon P. Lucke-Wold

  • University of Florida, Florida
Brankica Vasiljevic

Brankica Vasiljevic

  • NMC Royal Hospital, UAE
bruce

Bruce Ogden

  • Director of Operations US Foods USA
Cornelia Beyer

Cornelia Beyer

  • University of Hull, UK
Gabriela Barsov

Gabriela Barsov

  • Macedonia
Grazzia Rey

Grazzia Rey

  • University of the Republic, Uruguay
Hadi Salloum

Hadi Salloum

  • UAE
Heather Carmello

Heather Carmello

  • University of Rochester, USA
Howard Weber

Howard Weber

  • Penn State Hershey Childrens Hospital, USA
Ilknur AydınAvci

Ilknur AydınAvci

  • Turkey
Irene Hamrick

Irene Hamrick

  • University of Cincinnati, USA
José De Jesús Curiel Valdés

José De Jesús Curiel Valdés

  • Clínical Patology, Mexico
Lloyd L. Tran

Lloyd L. Tran

  • Biomed Industries, USA
Luca Roncati

Luca Roncati

  • University Hospital of Modena, Italy
Mahmoud Al Cheikh Ahmad

Mahmoud Al Cheikh Ahmad

  • UAE
Maria Braoudaki

Maria Braoudaki

  • University of Hertfordshire , United Kingdom
Marina F Gubkina

Marina F Gubkina

  • National Research Medical University, Russia
Muhamad Akhal

Muhamad Akhal

  • UAE
Peter Krcho

Peter Krcho

  • Pavol Jozef safarik University, Slovakia
Pinghong Zhou

Pinghong Zhou

  • Fudan University, China
Raffaele Pilla

Raffaele Pilla

  • University of Salerno, Italy
Ruut Veenhoven

Ruut Veenhoven

  • Seres Therapeutics, United States
said

Said Moustafa M. El-deib

  • Yas Clinic Khalifa City UAE
Sajidxa Marino

Sajidxa Marino

  • Central University of Venezuela, Venezuela
Sajidxa Marino

Sajidxa Marino

  • Central University of Venezuela, Venezuela
sam

Sam Vaknin

  • Southern Federal University, Russia
Sandra Vélez Candelario

Sandra Vélez Candelario

  • Catholic University of Puerto Rico, USA
Simon Treissman

Simon Treissman

  • Royal Inland Hospital, Canada
Taylor Bean

Taylor Bean

  • Salmon Arm, Canada
thiago

Thiago Hoesker

  • Neuro surgeon , Brazil
Tracy Roake

Tracy Roake

  • Danat Al Emarat Hospital, UAE
Vladimir Zajac

Vladimir Zajac

  • Cancer Research Institute, Slovakia
willium

William J Rowe

  • Specialist in Medicine, USA
Yu You Liu

Yu You Liu

  • National Chung Hsing University, Taiwan

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Psychiatry Dubai Expo 2025

It is our great pleasure to welcome you to the 21st Dubai Conference and expo On Psychiatry and Neuropsychology which is going to be held from February 25-26, 2025  in Dubai,UAE

The theme of our conference is based on “Exploring the Possibilities to Treat Psychiatric, Psychological Disorders and mental health”. The conference invites all Nurses, Psychiatrists, Neuropsychiatric, Neurosurgeons, Neurologists, Emergency medicine specialists, International speakers, Scientists, Researchers, University Professors, Students, College Faculties, and Healthcare professionals to share their experience in this broad field.

We invite you to join us at Psychiatry Dubai Expo 2025 Conference where you will be sure to have a meaningful experience with scholars from around the world. Generous response and active participation from the Editorial Board Members of conference-related Journals as well as from the scientists, researchers, and leaders in the field will make this conference one of the most successful and productive events in 2025.

Why join?

Learn and share through Workshops and Interactive Sessions

Workshops and interactive sessions involve extensive interaction between the presenters and delegates around an idea or hands-on experience of a practice. These interactive sessions may take the form of a panel, staged conversation, or debate – all involving substantial interaction with the participants. Therefore a variety of sessions, keynote lectures, symposiums, workshops, and poster presentations will give you an opportunity to share and present research to your colleagues from around the world.

Meet your subject matter experts

Subject Matter Experts will lead you in current research & development. They help you with research queries, and content, identify the objectives, and ensure your research is scientifically acceptable.

Networking/ round table discussions

Psychiatry Dubai Expo 2025 has its specially designed networking and round table discussion session, which brings together clinicians, health professionals, and patients on the front lines of psychiatric care to learn from each other and build professional networks and collaboration.

Who can join the event?

Psychiatry Dubai Expo 2025, provides the participants with different modes or ways to participate under either academic/student/business category

For Researchers & Faculty:

For Universities, Associations & Societies:

For Students & Research Scholars:

For Business Delegates:

For Companies:

Target Audience

Conference highlights 

Track 1: Psychiatry and Psychiatric Disorders

  1. Anxiety Disorders: Generalized anxiety disorder, panic disorder, social anxiety disorder.
  2. Stress Disorders: Acute stress disorder, post-traumatic stress disorder (PTSD).
  3. Major Depressive Disorder: Clinical depression, dysthymia.
  4. Mood Disorders: Bipolar disorder, cyclothymia.
  5. Schizophrenia and Psychotic Disorders: Schizophrenia, delusional disorder.

Track 2: Brain Disorders

  1. Alzheimer’s Disease: Early-onset and late-onset Alzheimer’s.
  2. Dementias: Vascular dementia, Lewy body dementia.
  3. Brain Cancer: Glioblastoma, meningioma.
  4. Epilepsy and Seizure Disorders: Generalized epilepsy, focal seizures.
  5. Movement Disorders: Parkinson’s disease, essential tremor.

Track 3: Psychology & Mental Health

  1. Emotional Regulation: Techniques for managing emotions.
  2. Cognitive Behavioral Approaches: CBT techniques, cognitive distortions.
  3. Social and Interpersonal Skills: Building and maintaining relationships.
  4. Stress Management: Stress reduction techniques, mindfulness.
  5. Developmental Psychology: Psychological changes across the lifespan.

Track 4: Counselling & Psychotherapy

  1. Short-Term Counseling: Problem-focused therapy, solution-focused therapy.
  2. Long-Term Psychotherapy: Psychodynamic therapy, humanistic therapy.
  3. Cognitive Behavioral Therapy (CBT): Techniques and applications.
  4. Dialectical Behavior Therapy (DBT): Skills and methods.
  5. Family and Couples Therapy: Approaches and techniques for relational issues.

Track 5: Child and Adolescent Psychiatry

  1. ADHD: Diagnosis, treatment, and management.
  2. Autism Spectrum Disorders: Diagnosis, intervention strategies.
  3. Anxiety and Depression in Youth: Identification and treatment.
  4. Behavioral Disorders: Oppositional defiant disorder, conduct disorder.
  5. Developmental Delays: Early intervention and treatment strategies.

Track 6: Stress, Depression, and Anxiety

  1. Acute Stress: Symptoms and management strategies.
  2. Chronic Stress: Long-term impacts and coping mechanisms.
  3. Major Depressive Disorder: Diagnosis and treatment.
  4. Generalized Anxiety Disorder: Symptoms and therapeutic approaches.
  5. Coping Strategies: Techniques for managing stress, depression, and anxiety.

Track 7: Neuropsychiatry

  1. Brain Function and Behavior: Neuroanatomy and its impact on behavior.
  2. Cognitive Neuropsychiatry: Understanding cognitive disorders.
  3. Neurodevelopmental Disorders: Autism, ADHD.
  4. Neurodegenerative Disorders: Alzheimer’s disease, Parkinson’s disease.
  5. Neuroimaging Techniques: MRI, PET scans in neuropsychiatry.

Track 8: Autism Spectrum Disorder

  1. Early Diagnosis and Intervention: Screening and early intervention strategies.
  2. Behavioral Therapy: Applied Behavior Analysis (ABA), social skills training.
  3. Communication Disorders: Speech and language therapy.
  4. Educational Strategies: School-based interventions and support.
  5. Family Support: Resources and support for families.

Track 9: Addiction, Addictive Disorders, and Recovery

  1. Substance Use Disorders: Alcohol, opioids, stimulants.
  2. Behavioral Addictions: Gambling, internet addiction.
  3. Treatment Modalities: Detoxification, inpatient and outpatient treatments.
  4. Recovery and Relapse Prevention: Strategies for maintaining sobriety.
  5. Support Systems: Role of support groups and family.

Track 10: ADHD & Learning Disorders

  1. ADHD in Children: Symptoms, diagnosis, and treatment.
  2. ADHD in Adults: Symptoms, management strategies.
  3. Dyslexia: Identification and intervention.
  4. Dysgraphia: Treatment and educational strategies.
  5. Dyscalculia: Strategies for math-related learning challenges.

Track 11: Geriatric Psychiatry

  1. Cognitive Decline: Normal aging vs. pathological decline.
  2. Depression in Older Adults: Symptoms and treatment.
  3. Dementia and Alzheimer’s Disease: Diagnosis and management.
  4. Anxiety Disorders in the Elderly: Identification and treatment.
  5. Substance Abuse: Patterns and treatment in older adults.

Track 12: Suicide & Prevention

  1. Risk Factors: Identifying individuals at risk.
  2. Prevention Strategies: Crisis intervention and long-term prevention.
  3. Therapeutic Approaches: CBT for suicide prevention.
  4. Community and Support Programs: Local and national initiatives.
  5. Postvention: Support for those affected by a suicide.

Track 13: Mental Health

  1. Emotional Well-being: Factors influencing emotional health.
  2. Mental Health Disorders: Overview of common disorders.
  3. Therapeutic Approaches: Overview of different therapies.
  4. Crisis Management: Dealing with acute mental health crises.
  5. Mental Health Promotion: Strategies for improving mental health.

Track 14: Adult Mental Health

  1. Depression and Mood Disorders: Diagnosis and treatment.
  2. Anxiety Disorders: Management strategies.
  3. Bipolar Disorder: Symptoms and treatment options.
  4. Schizophrenia: Overview and management.
  5. Stress Management: Techniques for adults.

Track 15: Child and Adolescent Mental Health

  1. Early Childhood Disorders: Autism, ADHD.
  2. Adolescent Depression and Anxiety: Identification and treatment.
  3. Behavioral Issues: Oppositional defiant disorder, conduct disorder.
  4. Family Dynamics: Impact on mental health and treatment.
  5. School-based Interventions: Role of educators and school counselors.

Track 16: Mental Illness

  1. Major Depression: Symptoms, diagnosis, and treatment.
  2. Bipolar Disorder: Understanding and managing mood swings.
  3. Schizophrenia: Symptoms and therapeutic approaches.
  4. Anxiety Disorders: Various types and treatments.
  5. Personality Disorders: Overview and management.

Track 17: Impulse-Control Disorder

  1. Intermittent Explosive Disorder: Symptoms and management.
  2. Kleptomania: Understanding and treatment.
  3. Pyromania: Symptoms and therapeutic approaches.
  4. Compulsive Gambling: Diagnosis and treatment.
  5. General Impulse-Control Disorders: Overview and interventions.

Track 18: Neurodevelopmental Disorders

  1. Autism Spectrum Disorder: Diagnosis, treatment, and support.
  2. ADHD: Understanding and managing symptoms.
  3. Intellectual Disabilities: Diagnosis and support strategies.
  4. Specific Learning Disabilities: Interventions and educational support.
  5. Developmental Coordination Disorder: Symptoms and management.

Track 19: Post-traumatic Stress Disorder (PTSD)

  1. Symptoms of PTSD: Identifying and understanding symptoms.
  2. Therapeutic Approaches: CBT, EMDR, and other therapies.
  3. Trauma-Informed Care: Principles and practices.
  4. Coping Strategies: Techniques for managing PTSD symptoms.
  5. Support Systems: Role of community and family.

Track 20: Bipolar Disorder

  1. Manic Episodes: Symptoms and treatment strategies.
  2. Depressive Episodes: Identification and management.
  3. Mixed Episodes: Understanding and treatment.
  4. Medication Management: Types of medications and their effects.
  5. Psychotherapy Approaches: CBT, DBT, and other therapies.

Track 21: Personality Disorders

  1. Borderline Personality Disorder: Symptoms and therapeutic approaches.
  2. Narcissistic Personality Disorder: Understanding and treatment.
  3. Antisocial Personality Disorder: Diagnosis and management.
  4. Avoidant Personality Disorder: Treatment and coping strategies.
  5. Obsessive-Compulsive Personality Disorder: Symptoms and interventions.

Market analysis 

The Psychiatry and Mental Health Conference is a pivotal event in the healthcare landscape, providing a platform for professionals, researchers, and experts to converge and discuss the latest advancements, challenges, and trends in the field. This conference plays a crucial role in fostering collaboration, sharing knowledge, and promoting innovation in psychiatry and mental health.

Market analysis of this conference reveals a growing demand for a comprehensive understanding of mental health issues and the need for effective strategies to address them. With the increasing recognition of mental health as a global concern, the conference attracts a diverse audience, including psychiatrists, psychologists, social workers, and policymakers. The market for mental health conferences is expanding as awareness of mental health issues rises, leading to an increased emphasis on research, treatment modalities, and preventative measures.

Key drivers for the growth of this market include rising mental health challenges, the integration of technology in mental health care, and a growing acceptance of holistic approaches. Additionally, the conference serves as a platform for pharmaceutical companies, mental health clinics, and technology providers to showcase their latest products and services.

Overall, the Psychiatry and Mental Health Conference is a vital hub for networking, knowledge exchange, and business development in the mental health sector. As the importance of mental health continues to gain prominence, the market for such conferences is anticipated to witness sustained growth, reflecting the increasing commitment to addressing and mitigating mental health issues on a global scale.

The Future of Neuropsychology and Its Global Market Exploration

Neuropsychology, the study of how brain function affects behavior, cognition, and emotions, is poised for significant growth worldwide. This field combines principles from psychology and neurology to better understand, diagnose, and treat conditions that affect the brain. As technological advancements and a greater emphasis on mental health drive demand, the global market for neuropsychology is expanding, with new opportunities and challenges on the horizon.

Key Trends Shaping the Future of Neuropsychology

  1. Advancements in Neuroimaging and Brain Mapping
    The future of neuropsychology is being revolutionized by breakthroughs in neuroimaging technologies such as functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and magnetoencephalography (MEG). These tools allow neuropsychologists to visualize and understand brain activity in real-time, improving the accuracy of diagnoses and enabling more personalized treatment plans for neurological and psychiatric conditions. Enhanced imaging techniques are also being used to track changes in brain function over time, leading to better monitoring of disease progression and treatment outcomes.
  2. Integration of Artificial Intelligence (AI) and Machine Learning
    AI and machine learning are transforming neuropsychology by enabling the analysis of complex datasets, including neuroimaging results, genetic information, and patient histories. These technologies help identify patterns that may not be visible to the human eye, leading to earlier and more precise diagnoses. AI-driven tools are also being developed to predict patient outcomes and recommend personalized interventions, enhancing the effectiveness of neuropsychological treatments. The use of AI in neuropsychology is expected to grow, making data-driven decision-making a standard part of clinical practice.
  3. Rise of Digital Health and Tele-Neuropsychology
    The COVID-19 pandemic accelerated the adoption of digital health technologies, including telemedicine, in neuropsychology. Remote cognitive assessments, virtual therapy sessions, and digital mental health platforms have become integral parts of patient care. Tele-neuropsychology expands access to neuropsychological services, particularly for patients in remote or underserved areas. It also allows continuous monitoring and support for patients with chronic conditions, providing a more comprehensive approach to care. The trend towards digital health is expected to continue, driven by technological advancements and a growing demand for convenient, accessible healthcare solutions.
  4. Neurorehabilitation and Cognitive Training Technologies
    Innovations in virtual reality (VR), augmented reality (AR), and brain-computer interfaces (BCIs) are opening new avenues for neurorehabilitation and cognitive training. These technologies provide immersive, interactive environments that enhance cognitive rehabilitation for patients recovering from brain injuries, strokes, or neurodegenerative diseases. For example, VR-based neurorehabilitation programs are being used to improve memory, attention, and executive function in patients with traumatic brain injuries. As these technologies become more sophisticated and accessible, they will play a larger role in neuropsychological care, offering personalized and engaging rehabilitation experiences.
  5. Personalized Medicine and Genetic Research
    Personalized medicine is becoming increasingly important in neuropsychology, with a growing focus on how individual genetic profiles affect brain function and mental health. Research into genetic markers and biomarkers is helping to identify individuals at risk for specific neurological or psychiatric conditions, enabling earlier interventions and more targeted treatments. For instance, genetic research is uncovering links between specific gene variants and mental health conditions such as schizophrenia, depression, and Alzheimer’s disease. As our understanding of these genetic factors deepens, neuropsychologists will be better equipped to develop personalized treatment plans that consider each patient’s unique genetic makeup.

Global Market Potential and Opportunities

The global market for neuropsychology is expanding rapidly, driven by several key factors:

  1. Increasing Awareness of Mental Health and Neurological Disorders
    There is a growing awareness of mental health and neurological disorders worldwide, leading to increased demand for neuropsychological services. Conditions such as Alzheimer’s disease, Parkinson’s disease, ADHD, autism, and traumatic brain injuries are becoming more prevalent, partly due to aging populations and improved diagnostic capabilities. This heightened awareness is driving demand for neuropsychological assessments, therapies, and interventions, creating new opportunities for growth in the field.
  2. Aging Population and Neurodegenerative Diseases
    As the global population ages, the prevalence of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and dementia is rising. Neuropsychologists play a crucial role in diagnosing and managing these conditions, providing cognitive assessments, developing treatment plans, and offering support for patients and their families. The increasing demand for neuropsychological services related to aging and neurodegenerative diseases is expected to drive market growth in the coming years, particularly in developed countries with aging populations.
  3. Expanding Healthcare Infrastructure in Emerging Markets
    Emerging markets, particularly in Asia, the Middle East, and Latin America, are experiencing rapid growth in healthcare infrastructure and services. These regions are investing heavily in advanced medical technologies, research facilities, and specialized care, creating new opportunities for neuropsychology. For example, countries like China and India are expanding their healthcare systems to accommodate a growing middle class with increased access to healthcare services. As these markets continue to develop, the demand for neuropsychological expertise and services is expected to rise, offering significant growth potential for the field.
  4. Integration with Other Disciplines
    Neuropsychology is increasingly being integrated with other disciplines, such as neurology, psychiatry, rehabilitation, education, and even corporate wellness programs. This interdisciplinary approach allows for more comprehensive care and opens new avenues for neuropsychological services. For example, neuropsychologists are collaborating with neurologists to develop more effective treatment plans for patients with complex conditions involving both neurological and psychiatric components. In the corporate sector, neuropsychological principles are being applied to enhance employee well-being, productivity, and leadership development, creating new market opportunities.
  5. Research and Development in Cognitive Neuroscience
    Ongoing research and development in cognitive neuroscience are uncovering new insights into brain function and cognition, leading to innovative diagnostic and therapeutic approaches. The field of neuropsychology is at the forefront of these advancements, with researchers exploring new ways to understand and treat cognitive impairments, mood disorders, and behavioral conditions. Investment in R&D is expected to drive further growth in the neuropsychology market, as new discoveries and innovations continue to emerge.

Challenges and Considerations

Despite the promising future, several challenges need to be addressed for the continued growth of neuropsychology:

  • Access to Care and Training: Access to neuropsychological services is limited in many parts of the world, particularly in low-income and rural areas. Additionally, there is a need for more specialized training programs to develop a skilled workforce of neuropsychologists, particularly in emerging markets.
  • Ethical and Regulatory Concerns: The use of advanced technologies, such as AI and neuroimaging, raises ethical and regulatory concerns regarding data privacy, consent, and the potential misuse of information. Establishing robust ethical guidelines and regulatory frameworks is essential for ensuring the responsible use of these technologies in neuropsychology.
  • Cost of Advanced Technologies: The high cost of advanced neuropsychological technologies, such as neuroimaging and VR-based rehabilitation tools, can be a barrier to widespread adoption, particularly in resource-constrained settings. Reducing costs and improving access to these technologies will be critical for expanding neuropsychological services globally.

– Quick Contact –